The San Diego-based company now offers Dexcom G7 in the U.K., Ireland, Germany, Austria and Hong Kong. Availability covers people with diabetes aged two years and older. The launch marks the first major milestone in the availability of the continuous glucose monitor (CGM).
Dexcom intends to introduce the G7 in New Zealand and South Africa “in the weeks ahead,” according to a news release. It plans to release it in additional markets soon after — and is now aiming for a large U.S. launch in Q1 2023.